Literature DB >> 19870995

CONSTITUENTS OF ELEMENTARY BODIES OF VACCINIA : I. CERTAIN BASIC ANALYSES AND OBSERVATIONS ON LIPID COMPONENTS OF THE VIRUS.

C L Hoagland1, J E Smadel, T M Rivers.   

Abstract

The results of chemical analyses reveal that it is possible to secure preparations of elementary bodies of vaccinia that possess a considerable uniformity in their chemical constituents. Furthermore, the amounts of certain of these constituents, namely, nitrogen, alpha-amino nitrogen after hydrolysis, phosphorus, total fat, phospholipid, neutral fat, reducing sugar after hydrolysis, and cystine, in the purified virus are significantly different from those in the various materials discarded during the process of purification. The amounts of phospholipid and neutral fat in the virus preparations are not appreciably affected by extraction with ethyl ether or by digestion with lipase, procedures which do not inactivate the virus. Cholesterol, on the contrary, is apparently completely removed by these manipulations, and hence is not considered to play an important part in the economy of the virus.

Entities:  

Year:  1940        PMID: 19870995      PMCID: PMC2135105          DOI: 10.1084/jem.71.6.737

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  5 in total

1.  A SIMPLE GRINDER FOR SOFT TISSUES.

Authors:  C Tenbroeck
Journal:  Science       Date:  1931-07-24       Impact factor: 47.728

2.  SOME CONSTITUENTS OF ELEMENTARY BODIES OF VACCINIA.

Authors:  J E Smadel; G I Lavin; R J Dubos
Journal:  J Exp Med       Date:  1940-02-29       Impact factor: 14.307

3.  ESTIMATION OF THE PURITY OF PREPARATIONS OF ELEMENTARY BODIES OF VACCINIA.

Authors:  J E Smadel; T M Rivers; E G Pickels
Journal:  J Exp Med       Date:  1939-09-30       Impact factor: 14.307

4.  IMMUNOLOGICAL AND CHEMICAL INVESTIGATIONS OF VACCINE VIRUS : II. CHEMICAL ANALYSIS OF ELEMENTARY BODIES OF VACCINIA.

Authors:  T P Hughes; R F Parker; T M Rivers
Journal:  J Exp Med       Date:  1935-08-31       Impact factor: 14.307

5.  STATISTICAL STUDIES OF THE NATURE OF THE INFECTIOUS UNIT OF VACCINE VIRUS.

Authors:  R F Parker
Journal:  J Exp Med       Date:  1938-04-30       Impact factor: 14.307

  5 in total
  14 in total

1.  [Experiments with the micromethod of complement fixation reaction].

Authors:  R WIGAND
Journal:  Z Hyg Infektionskr       Date:  1956

2.  [Hemagglutination by vaccinia virus. I. Method].

Authors:  R WIGAND
Journal:  Arch Gesamte Virusforsch       Date:  1956

3.  [Virus diseases in otorhinolaryngology region].

Authors:  R HAAS
Journal:  Arch Ohren Nasen Kehlkopfheilkd       Date:  1955-05-02

4.  The Vaccinial Infection of Fowls of Different Ages in Relation to the Antiviral Power of the Blood.

Authors:  F Duran-Reynals
Journal:  Yale J Biol Med       Date:  1941-05

5.  CONSTITUENTS OF ELEMENTARY BODIES OF VACCINIA : III. THE EFFECT OF PURIFIED ENZYMES ON ELEMENTARY BODIES OF VACCINIA.

Authors:  C L Hoagland; S M Ward; J E Smadel; T M Rivers
Journal:  J Exp Med       Date:  1940-11-30       Impact factor: 14.307

6.  THE LS-ANTIGEN OF VACCINIA : IV. CHEMICAL ANALYSIS OF LS AND THE EFFECT OF CHYMOTRYPSIN ON LS.

Authors:  J E Smadel; C L Hoagland; T Shedlovsky
Journal:  J Exp Med       Date:  1943-02-01       Impact factor: 14.307

7.  MORPHOLOGICAL STRUCTURE OF THE VIRUS OF VACCINIA.

Authors:  R H Green; T F Anderson; J E Smadel
Journal:  J Exp Med       Date:  1942-06-01       Impact factor: 14.307

8.  ELECTROPHORETIC STUDIES ON ELEMENTARY BODIES OF VACCINIA.

Authors:  T Shedlovsky; J E Smadel
Journal:  J Exp Med       Date:  1940-10-31       Impact factor: 14.307

9.  CONSTITUENTS OF ELEMENTARY BODIES OF VACCINIA : V. A FLAVIN ASSOCIATED WITH THE PURIFIED VIRUS.

Authors:  C L Hoagland; S M Ward; J E Smadel; T M Rivers
Journal:  J Exp Med       Date:  1941-07-31       Impact factor: 14.307

10.  CONSTITUENTS OF ELEMENTARY BODIES OF VACCINIA : IV. DEMONSTRATION OF COPPER IN THE PURIFIED VIRUS.

Authors:  C L Hoagland; S M Ward; J E Smadel; T M Rivers
Journal:  J Exp Med       Date:  1941-06-30       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.